Dementia, Vascular
An imprecise term referring to dementia associated with CEREBROVASCULAR DISORDERS, including CEREBRAL INFARCTION (single or multiple), and conditions associated with chronic BRAIN ISCHEMIA. Diffuse, cortical, and subcortical subtypes have been described. (From Gerontol Geriatr 1998 Feb;31(1):36-44)
Subtype terms (2)
More specific conditions that are subtypes of Dementia, Vascular in the MeSH hierarchy.
- CADASIL
9 drugs (6 approved, 3 experimental)
- Dementia, Multi-Infarct
Drugs by status
Phase 4 trials (14)
Phase 3 trials (19)
Phase 2 trials (14)
Other trials (4)
Organizations
Organization Involved with Phase 4 Indications (12)
Organization Involved with Phase 3 Indications (17)
- AstraZeneca
- Pfizer
- Novartis
- Merz
- Shineway Pharmaceutical Co.,Ltd
- National Institute of Mental Health (NIMH)
- University of Pittsburgh
- University of Sydney
- Capital Medical University
- University of Amsterdam
- Free University of Amsterdam
- Janssen Pharmaceutica NV
- University of New South Wales
- Western Psychiatric Institute & Clinic
- General Electric
- Johnson and Johnson
- Shijiazhuang Pharma Group (CSPC)
Organization Involved with Phase 2 Indications (35)
- Charsire Biotechnology Corp.
- Dong-A Pharmaceutical
- Sinphar Pharmaceutical Co., Ltd
- A2 Healthcare Taiwan Corporation
- Shanghai Hutchison Pharmaceuticals Limited
- University of Pennsylvania
- Chang Gung University
- University of London
- Jilin University
- Nanjing Medical University
- National Cheng Kung University
- Oregon Health and Science University
- Radboud University
- Shanghai University of Traditional Chinese Medicine
- University of Glasgow
- Hunan University of Traditional Chinese Medicine
- University of Copenhagen
- Zhejiang University
- First People's Hospital of Chenzhou
- Southeast University
- Southern Medical University
- Guangzhou University
- Hospital of Traditional Chinese and Western Medicine of Jilin Province
- Government of China
- Vincent van Gogh voor Geestelijke Gezondheidszorg
- Chengdu University of Traditional Chinese Medicines
- Tianjin University
- The Florey Institute of Neuroscience and Mental Health
- Alzheimer's Society UK
- Health Valley, Netherlands
- +5 more
Organization Involved with Phase 1 Indications (1)
Organization Involved with Other Experimental Indications (4)